499 related articles for article (PubMed ID: 27226497)
1. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Chen HC; Chen YL; Guo BF; Tsai TH; Chang JP; Pan KL; Lin YS; Chen MC
Can J Cardiol; 2013 Sep; 29(9):1110-7. PubMed ID: 23474139
[TBL] [Abstract][Full Text] [Related]
3. Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.
He H; Ke BB; Li Y; Han FS; Li X; Zeng YJ
J Interv Card Electrophysiol; 2017 Oct; 50(1):65-83. PubMed ID: 28842832
[TBL] [Abstract][Full Text] [Related]
4. Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
Demir GG; Guler GB; Guler E; Güneş H; Kizilirmak F; Karaca İO; Omaygenç MO; Çakal B; Olgun E; Savur U; Ibisoglu E; Barutçu I; Kiliçaslan F
Acta Cardiol; 2017 Feb; 72(1):47-52. PubMed ID: 28597740
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
Black-Maier E; Kim S; Steinberg BA; Fonarow GC; Freeman JV; Kowey PR; Ansell J; Gersh BJ; Mahaffey KW; Naccarelli G; Hylek EM; Go AS; Peterson ED; Piccini JP;
Clin Cardiol; 2017 Sep; 40(9):746-751. PubMed ID: 28543401
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
[TBL] [Abstract][Full Text] [Related]
7. Impact of peri-procedural management of direct oral anticoagulants on pocket haematoma after cardiac electronic device implantation: the StimAOD multicentre prospective study.
Martin AC; Weizman O; Sellal JM; Algalarrondo V; Amara W; Bouzeman A; Gandjbakhch E; Lellouche N; Louembe J; Menet A; Roumegou P; Treguer F; Godier A; Boveda S; Garcia R; Marijon E
Europace; 2023 May; 25(5):. PubMed ID: 36932714
[TBL] [Abstract][Full Text] [Related]
8. Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.
Essebag V; Healey JS; Ayala-Paredes F; Kalfon E; Coutu B; Nery P; Verma A; Sapp J; Philippon F; Sandhu RK; Coyle D; Eikelboom J; Wells G; Birnie DH
Am Heart J; 2016 Mar; 173():102-7. PubMed ID: 26920602
[TBL] [Abstract][Full Text] [Related]
9. Risk factors associated with bleeding after multi antithrombotic therapy during implantation of cardiac implantable electronic devices.
Ishibashi K; Miyamoto K; Kamakura T; Wada M; Nakajima I; Inoue Y; Okamura H; Noda T; Aiba T; Kamakura S; Shimizu W; Yasuda S; Akasaka T; Kusano K
Heart Vessels; 2017 Mar; 32(3):333-340. PubMed ID: 27469320
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of pocket hematoma after cardiac device implantation and replacement.
Ferretto S; Mattesi G; Migliore F; Susana A; De Lazzari M; Iliceto S; Leoni L; Bertaglia E
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):123-127. PubMed ID: 31789710
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices.
Korantzopoulos P; Letsas KP; Liu T; Fragakis N; Efremidis M; Goudevenos JA
Europace; 2011 Dec; 13(12):1669-80. PubMed ID: 21788280
[TBL] [Abstract][Full Text] [Related]
12. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
Beton O; Saricam E; Kaya H; Yucel H; Dogdu O; Turgut OO; Berkan O; Tandogan I; Yilmaz MB
BMC Cardiovasc Disord; 2016 Apr; 16():73. PubMed ID: 27105588
[TBL] [Abstract][Full Text] [Related]
13. Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.
Zacà V; Marcucci R; Parodi G; Limbruno U; Notarstefano P; Pieragnoli P; Di Cori A; Bongiorni MG; Casolo G
Europace; 2015 Jun; 17(6):840-54. PubMed ID: 25712980
[TBL] [Abstract][Full Text] [Related]
14. Rationale, study design, and pilot phase of tHE Management of AntiThrOMbotic therApy (HEMATOMA) in patients undergoing electrophysiological device surgery: Italian National Multicenter Observational REgistry.
Zacà V; Breschi M; Mandorli A; Panchetti L; Ricciardi G; Viani S; Notarstefano P
J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):897-899. PubMed ID: 28594654
[TBL] [Abstract][Full Text] [Related]
15. Frequency of "Pocket" Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study).
Malagù M; Trevisan F; Scalone A; Marcantoni L; Sammarco G; Bertini M
Am J Cardiol; 2017 Apr; 119(7):1036-1040. PubMed ID: 28153344
[TBL] [Abstract][Full Text] [Related]
16. Device implantation for patients on antiplatelets and anticoagulants: Use of suction drain.
Mukherjee SS; Saggu D; Chennapragada S; Yalagudri S; Nair SG; CalamburNarasimhan
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S389-S393. PubMed ID: 30595295
[TBL] [Abstract][Full Text] [Related]
17. Pocket related complications following cardiac electronic device implantation in patients receiving anticoagulation and/or dual antiplatelet therapy: prospective evaluation of different preventive strategies.
Awada H; Geller JC; Brunelli M; Ohlow MA
J Interv Card Electrophysiol; 2019 Apr; 54(3):247-255. PubMed ID: 30460588
[TBL] [Abstract][Full Text] [Related]
18. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
[TBL] [Abstract][Full Text] [Related]
19. Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: A single-center randomized prospective pilot trial.
Ricciardi D; Creta A; Colaiori I; Scordino D; Ragni L; Picarelli F; Calabrese V; Providência R; Ioannou A; Di Sciascio G
Pacing Clin Electrophysiol; 2018 Nov; 41(11):1476-1480. PubMed ID: 30132926
[TBL] [Abstract][Full Text] [Related]
20. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
Thal S; Moukabary T; Boyella R; Shanmugasundaram M; Pierce MK; Thai H; Goldman S
Pacing Clin Electrophysiol; 2010 Apr; 33(4):385-8. PubMed ID: 20059711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
